2023/51/D/NZ7/01557
Keywords:
Inhalable powder blends Inhaled microparticles Local pulmonary drug delivery Personalized inhaled therapy Theranostic agent Magnetic Resonance Imaging (MRI) Lung aspergillosis Voriconazole Isavuconazole
Descriptors:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj.
Principal investigator (from the host institution):
dr Gabriela Wyszogrodzka-Gaweł
Number of co-investigators in the project: 7
Call: SONATA 19 - announced on 2023-09-18
Amount awarded: 3 152 400 PLN
Project start date (Y-m-d): 2024-12-10
Project end date (Y-m-d): 2027-12-09
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.